Orally inhaled flecainide favorable for conversion of atrial fibrillation to sinus rhythm: Insights from INSTANT phase 2 trial Medha Baranwal18 April 2024 9:45 AM ISTUSA: Findings from the INSTANT phase 2 trial showed that orally inhaled flecainide passed muster for converting atrial fibrillation (AF) to sinus...
Using two sets of defibrillation pads more effective treatment strategy for obese atrial fibrillation patients: Study Medha Baranwal8 Dec 2023 10:15 AM ISTUSA: A second set of defibrillation pads for dual direct current cardioversion (DDCV) safely improved the success of the procedure for atrial...
Flecainide useful for achieving and maintaining Sinus rhythm among young patients with rheumatic AF Aditi15 Oct 2023 8:00 PM ISTRheumatic heart disease is the common etiology in patients with Atrial fibrillation (AF). These patients have a higher rate of thromboembolic...
AI-guided screening technique for Atrial fibrillation improves accuracy: Lancet Jacinthlyn Sylvia4 Oct 2022 7:30 PM ISTA new study conducted by Peter A. Noseworthy and colleagues showed that the yield for atrial fibrillation identification was raised and the efficacy...
Oral inhalation flecainide may help restore sinus rhythm in atrial fibrillation patients Dr. Nandita Mohan30 March 2022 6:00 PM ISTNetherlands: A recent study in the journal Circulation: Arrhythmia and Electrophysiology found the administration of flecainide via oral inhalation to...
Beta blockers may reduce mortality in cluster of young patients with AF and HF: Lancet Dr. Shravani Dali2 Sept 2021 10:45 AM ISTA statistically significant reduction in mortality is associated with beta blockers in a cluster of younger atrial fibrillation patients at lower...
